Internal Medicine, Hematology & Oncology · Oakland, CA
NPI
1780762575
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
275 W Macarthur Blvd
Oakland, CA, 94611
Phone (510) 752-1000
Groups this clinician bills Medicare through
Medicare paid, 2023
$101K
3,888 services
Medicare patients, 2023
20
Average age 64
Drug cost, 2024
$5.7M
1,023 prescriptions
Company payments, 2024
$155
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug David M Baer prescribed most often to Medicare patients was Brukinsa (Zanubrutinib), with 179 prescriptions and refills. In total David M Baer wrote 1,023 Medicare prescriptions that cost $5.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Brukinsa Zanubrutinib | 179 | 179 | 18 | $2.1M |
| Lenalidomide Generic | 118 | 118 | 13 | $1.3M |
| Dexamethasone Generic | 106 | 111 | 21 | $1,621 |
| Hydroxyurea Generic | 99 | 285 | 33 | $4,899 |
| Acyclovir Generic | 68 | 187 | 28 | $2,054 |
| Calquence Acalabrutinib Maleate | 56 | 56 | Under 11 | $554K |
| Prednisone Generic | 55 | 65 | 12 | $481 |
| Entecavir Generic | 42 | 113 | Under 11 | $1,039 |
| Ondansetron Hcl Generic | 35 | 38 | 16 | $377 |
| Pomalyst Pomalidomide | 30 | 30 | Under 11 | $698K |
| Sprycel Dasatinib | 30 | 30 | Under 11 | $256K |
| Prochlorperazine Maleate Generic | 24 | 24 | 13 | $347 |
| Imatinib Mesylate Generic | 20 | 27 | Under 11 | $1,293 |
| Alvaiz Eltrombopag Choline | 20 | 20 | Under 11 | $209K |
| Imbruvica Ibrutinib | 12 | 12 | Under 11 | $285K |
Brand drugs: 384 claims; generic drugs: 639 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid David M Baer $155 ($155 in general payments such as food, travel and fees) from 1 company. The largest payer was Alnylam Pharmaceuticals Inc. with $155.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $155 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.